Up-regulation of soluble Axl and Mer receptor tyrosine kinases negatively correlates with Gas6 in established multiple sclerosis lesions
about
The Gas6/TAM System and Multiple SclerosisLigand Activation of TAM Family Receptors-Implications for Tumor Biology and Therapeutic ResponsePolymorphisms in the receptor tyrosine kinase MERTK gene are associated with multiple sclerosis susceptibilityAssociation of plasma levels of Protein S with disease severity in multiple sclerosis.ADAM-17: the enzyme that does it all.GAS6 enhances repair following cuprizone-induced demyelination.Gas6 increases myelination by oligodendrocytes and its deficiency delays recovery following cuprizone-induced demyelinationTAM receptor tyrosine kinases: expression, disease and oncogenesis in the central nervous system.Targeted GAS6 delivery to the CNS protects axons from damage during experimental autoimmune encephalomyelitisAxl as a mediator of cellular growth and survivalGAS6 receptor status is associated with dormancy and bone metastatic tumor formationLoss of the receptor tyrosine kinase Axl leads to enhanced inflammation in the CNS and delayed removal of myelin debris during experimental autoimmune encephalomyelitisInduction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis.Primary myeloma interaction and growth in coculture with healthy donor hematopoietic bone marrow.Common and Low Frequency Variants in MERTK Are Independently Associated with Multiple Sclerosis Susceptibility with Discordant Association Dependent upon HLA-DRB1*15:01 Status.Oligodendrocyte Regeneration and CNS Remyelination Require TACE/ADAM17Growth arrest specific gene 6 protein concentration in cerebrospinal fluid correlates with relapse severity in multiple sclerosis.Growth arrest-specific protein 6 attenuates neutrophil migration and acute lung injury in sepsisPhagocyte dysfunction, tissue aging and degeneration.Receptor Tyrosine Kinase and Tyrosine Kinase Inhibitors: New Hope for Success in Multiple Sclerosis TherapyAxl and Mer Receptor Tyrosine Kinases: Distinct and Nonoverlapping Roles in Inflammation and Cancer?Key Roles of AXL and MER Receptor Tyrosine Kinases in Resistance to Multiple Anticancer Therapies.Diminished soluble levels of growth arrest specific protein 6 and tyrosine kinase receptor Axl in patients with rheumatoid arthritis.New candidates for CD4 T cell pathogenicity in experimental neuroinflammation and multiple sclerosis.A Janus role for MerTK in the outcome of septic shock.Erythrocyte efferocytosis modulates macrophages towards recovery after intracerebral hemorrhage.Loss of Gas6 and Axl signaling results in extensive axonal damage, motor deficits, prolonged neuroinflammation, and less remyelination following cuprizone exposure.Soluble TAM receptor tyrosine kinases in rheumatoid arthritis: correlation with disease activity and bone destruction.Antiphospholipid Antibodies Inhibit Trophoblast Toll-like Receptor and Inflammasome Negative Regulators.Gas6 as a putative noninvasive biomarker of hepatic fibrosis.The role of TAM family receptors and ligands in the nervous system: From development to pathobiology.Emerging PET Radiotracers and Targets for Imaging of Neuroinflammation in Neurodegenerative Diseases: Outlook Beyond TSPOOrthologous proteins of experimental de- and remyelination are differentially regulated in the CSF proteome of multiple sclerosis subtypes
P2860
Q28067131-D2A6F410-3355-48B6-A757-4843F3E7D1D7Q28072503-0FE20173-36EF-4AA7-B63B-485B16FC1248Q28742974-22C5739D-8037-4856-8609-E0832A12274DQ33692556-234D5CFA-2EB9-4FD2-AA57-71E0EBB94D0FQ33737421-7E99E135-D100-468E-9826-80853B35DF37Q33784396-C685E035-BEA9-4B02-A936-334B851C537CQ33851531-6A829C79-0499-45BE-89C2-79B1B6BF84E3Q34077622-4F4811B2-DEB3-4B47-BDE5-543AA3342A10Q34614563-EB881707-A7AD-48FF-8FDB-D38FA61606BFQ34619118-2A942876-0172-40CD-951E-D30415CC73F0Q34700694-15DD6DC1-ABF0-4A3B-8F13-4542B4F4BA74Q35063750-77597BE2-4888-49DB-A45E-D63D9639D576Q35810427-934CAE40-4B8F-4DC5-B9E0-6AD457935585Q35834665-455B807F-2926-465A-B784-B540CE7A4F56Q35962257-E105EE49-6149-4F52-B690-3347B9605508Q36017260-57E19120-6C1D-4757-9353-B9838E9D5C96Q36918304-C98DE9DA-ACA0-45F5-97BB-5596B7B0B0B2Q37325341-8B1DE1BA-941E-499B-AB13-343E09B79C68Q38113059-0D0B3E68-4EB4-42A7-A7CC-B55540143580Q38261946-4F94D0F7-ADB5-4BCC-A3AC-81F1ADCF0F42Q38936702-788101FC-5A0C-49CB-A78F-87143A9ABEBAQ39157476-BABB2CBB-1E61-4408-B754-DAC0BBD3F079Q39215790-FD6D9935-4490-45B4-A77E-C34228E47954Q41459008-854F2308-D881-489A-B1E9-D2E5FF5AB93BQ45045416-71593620-B044-42FD-9663-6456670D8929Q47240053-5D715F6D-D02D-4A1A-9E0D-874BA8EB96E3Q47963320-8E980281-29A0-4203-A189-B75FF09C07B2Q48284666-A37E81D2-869B-452E-B39E-E4B7E3093708Q49998565-9D1283AC-E3AF-4C6F-833C-C95317364F80Q51281899-C826477A-C314-4BCB-AB91-D5C1E292C174Q52669235-6D031B34-E0CE-45CF-9B32-4AD2A106E7D1Q58751451-138A4EA9-4DE7-4007-B1A7-B8CDFBB8D364Q58774884-3618CA79-E26B-4503-A4CE-A8C212B849B1
P2860
Up-regulation of soluble Axl and Mer receptor tyrosine kinases negatively correlates with Gas6 in established multiple sclerosis lesions
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Up-regulation of soluble Axl a ...... hed multiple sclerosis lesions
@en
Up-regulation of soluble Axl a ...... ed multiple sclerosis lesions.
@nl
type
label
Up-regulation of soluble Axl a ...... hed multiple sclerosis lesions
@en
Up-regulation of soluble Axl a ...... ed multiple sclerosis lesions.
@nl
prefLabel
Up-regulation of soluble Axl a ...... hed multiple sclerosis lesions
@en
Up-regulation of soluble Axl a ...... ed multiple sclerosis lesions.
@nl
P2093
P2860
P1476
Up-regulation of soluble Axl a ...... hed multiple sclerosis lesions
@en
P2093
Bridget Shafit-Zagardo
Cedric S Raine
Jason G Weinger
Kakuri M Omari
Kurt Marsden
P2860
P304
P356
10.2353/AJPATH.2009.080807
P407
P577
2009-06-18T00:00:00Z